Term Debt Syndication for USFDA, WHO-GMP Pharma & API Manufacturing Units
Consortium term debt, cleanroom machinery finance, and PLI incentive synchronization for pharmaceutical formulations, bulk drugs, and sterile injectables.
How does project finance work for Pharma & API manufacturing units in India?
Pharma and API project finance in India provides ₹15 Crore to ₹200+ Crore in consortium term debt for setting up or modernizing greenfield and brownfield formulation units, fermentation plants, and API bulk drug facilities. Regulated under strict USFDA, WHO-GMP, and environmental ZLD standards, bank underwriting evaluates process chemistry feasibility, key starting material (KSM) supply contracts, Central PLI scheme eligibility, and average DSCR benchmarks of 1.30x to 1.40x.
Institutional Underwriting & Structuring Benchmarks
Institutional underwriting parameters and facility structuring benchmarks across 45+ Scheduled Commercial Banks.
| Underwriting Metric | PSU Bank Consortium Norms | Private Bank / NBFC Norms | CreditCares Structuring Advantage |
|---|---|---|---|
| Mandate Range | ₹20 Cr to ₹200 Cr Consortium Capex | ₹15 Cr to ₹75 Cr Bilateral Line | Multi-bank syndication combining term capex and raw material working capital |
| Debt-to-Equity Ratio | 2:1 (67% Debt, 33% Promoter Equity) | 1.5:1 (Higher equity demand) | Recognition of capitalized R&D and pilot plant expenditure in equity contribution |
| Repayment Tenor | 7 to 10 Years door-to-door | 5 to 7 Years door-to-door | 10-Year tenor structured around drug master file (DMF) approval timelines |
| Moratorium Period | 18 to 24 Months (Civil + Validation batches) | 12 to 18 Months maximum | Extended moratorium covering regulatory inspection audits (USFDA/EU-GMP) |
| PLI Scheme Integration | Treated as cash inflow only post-sanction | Ignored in baseline debt sizing | Escrow structuring that utilizes Central PLI milestone grants to accelerate principal amortization |
Execution Architecture & Mandate Delivery
How CreditCares navigates multi-banking committees, technical appraisals, and compliance milestones.
- Central PLI Scheme & KSM Synchronization
- Aligning project investment milestones with the Central Government’s Production Linked Incentive (PLI) scheme for Key Starting Materials (KSMs) and APIs.
- Cleanroom & HVAC Modular Line Financing
- Structuring specialized machinery term loans for automated sterile fill-finish lines, isolators, and AHU air-handling systems meeting ISO Class 5 standards.
- Zero Liquid Discharge (ZLD) Effluent Debt
- Financing multiple-effect evaporators (MEE), biological treatment plants, and RO systems required for State Pollution Control Board environmental consent.
- Composite Working Capital & LC Limits
- Syndicating raw material import Letters of Credit (LC) and export packing credit (EPC) alongside term capex to ensure immediate liquidity upon commercial launch.
Credit Committee Bankability & Risk Mitigation
Why large-ticket applications fail at the Sanction Committee stage and how our desk immunizes your proposal:
Banks fear plant shutdown if USFDA or state regulators issue Warning Letters. We verify clean audit track records and QA/QC management credentials.
Margin compression from active ingredient spikes is stress-tested in CMA projections to ensure minimum DSCR remains ≥ 1.25x under adverse scenarios.
Disbursement of Phase-2 debt is strictly conditioned on receiving Consent to Establish (CTE). We ensure environmental consultant filings match bank covenants.
Mandate & Syndication Inquiries
Can PLI scheme subsidies be factored into bank debt calculations? ▼
What is the required debt-service coverage ratio (DSCR) for pharma project loans? ▼
Does CreditCares assist in syndicating working capital for export-oriented pharma units? ▼
What technical documentation is needed for an API plant bank loan? ▼
Can debt be raised for expanding R&D laboratories and bio-equivalence centers? ▼
Get an In-Principle Debt Appraisal
Fast-track routing for <₹50L to ₹500 Cr+ facilities. 3 quick inputs connect you directly to the appropriate regional credit desk (Mumbai / Kolkata / Pan-India).
Enquiry Successfully Logged & Dispatched!
Your enquiry reference is CC-MANDATE. Assigned to: Deal Desk.
Expedite Sanction with Company Profile
Supplying audited metrics accelerates lead bank term sheet issuance.
Complete Mandate Dossier Submitted!
Your comprehensive financial file is logged. A Senior Ex-Banker Credit Specialist from our Deal Desk will contact you directly within 24 business hours.
All Pharmaceutical Business Names & Categories We Fund
Pharmacists & Chemists
Working Capital CC/OD • ₹10L – ₹5Cr
Medicine Wholesalers & Distributors
Supply Chain Liquidity • ₹50L – ₹25Cr
Pharma & Medicine Manufacturers
Plant Project Debt • ₹10Cr – ₹200Cr+